Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
- PMID: 22441569
- DOI: 10.1007/s00125-012-2523-3
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
Abstract
Aims/hypothesis: The aim of the study was to investigate the timing of the appearance of autoantibodies associated with type 1 diabetes between birth and puberty, the natural fate of these autoantibodies and the predictive power of autoantibody concentrations for early progression to clinical diabetes.
Methods: Children were recruited to the Type 1 Diabetes Prediction and Prevention Project, an ongoing study based on HLA-conferred genetic risk. Autoantibodies against islet cells, insulin, GAD65 and islet antigen 2 were analysed at 3-12 month intervals, starting from birth.
Results: During the follow-up, 1,320 children (18.4% of the cohort of 7,165 children) were autoantibody positive in at least one sample. Altogether, 184 autoantibody-positive children progressed to type 1 diabetes. Seroconversion occurred at an early age in the progressors (median 1.5 years), among whom 118 (64%) and 150 (82%) seroconverted to autoantibody positivity before the age of 2 and 3 years, respectively. The incidence of seroconversion peaked at 1 year of age. Compared with other autoantibody-positive children, the median autoantibody levels were already markedly higher 3 to 6 months after the seroconversion in children who later progressed to diabetes.
Conclusions/interpretation: Early initiation of autoimmunity and rapid increases in autoantibody titres strongly predict progression to overt diabetes before puberty, emphasising the importance of early life events in the development of type 1 diabetes.
Comment in
-
Autoimmunity: Pinpointing progression to T1DM in children at genetic risk.Nat Rev Endocrinol. 2012 Apr 17;8(6):322. doi: 10.1038/nrendo.2012.58. Nat Rev Endocrinol. 2012. PMID: 22508095 No abstract available.
-
Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescence.Diabetologia. 2012 Jul;55(7):1873-6. doi: 10.1007/s00125-012-2583-4. Epub 2012 May 20. Diabetologia. 2012. PMID: 22610401
Similar articles
-
Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.Diabetologia. 2017 Jul;60(7):1284-1293. doi: 10.1007/s00125-017-4258-7. Epub 2017 Mar 31. Diabetologia. 2017. PMID: 28364254
-
Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.Diabetes Metab Res Rev. 2009 Oct;25(7):615-22. doi: 10.1002/dmrr.998. Diabetes Metab Res Rev. 2009. PMID: 19637309
-
Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.Diabetes. 2009 Dec;58(12):2835-42. doi: 10.2337/db08-1305. Epub 2009 Sep 15. Diabetes. 2009. PMID: 19755526 Free PMC article.
-
Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.Pediatr Diabetes. 2015 Nov;16(7):465-84. doi: 10.1111/pedi.12299. Epub 2015 Jul 23. Pediatr Diabetes. 2015. PMID: 26202050 Free PMC article. Review.
-
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count.Endocr Rev. 2021 Sep 28;42(5):584-604. doi: 10.1210/endrev/bnab013. Endocr Rev. 2021. PMID: 33881515 Review.
Cited by
-
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study).Arch Dis Child. 2024 Sep 25;109(10):812-817. doi: 10.1136/archdischild-2023-326697. Arch Dis Child. 2024. PMID: 38925883 Free PMC article.
-
The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study.J Endocr Soc. 2024 May 24;8(7):bvae103. doi: 10.1210/jendso/bvae103. eCollection 2024 May 23. J Endocr Soc. 2024. PMID: 38867880 Free PMC article.
-
Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.Diabetes Care. 2024 Aug 1;47(8):1424-1431. doi: 10.2337/dc24-0198. Diabetes Care. 2024. PMID: 38861550 Free PMC article.
-
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.Commun Med (Lond). 2024 Apr 6;4(1):66. doi: 10.1038/s43856-024-00478-y. Commun Med (Lond). 2024. PMID: 38582818 Free PMC article.
-
Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon.World J Diabetes. 2024 Feb 15;15(2):133-136. doi: 10.4239/wjd.v15.i2.133. World J Diabetes. 2024. PMID: 38464377 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials